Zena Therapeutics is dedicated to advancing drug discovery with a strong emphasis on patient safety, particularly in the realm of mental health and addiction therapeutics. The company aims to design and develop innovative treatments that not only prevent overdose fatalities but also enhance overall patient outcomes. Their mission underscores a commitment to addressing the critical issue of medication misuse, with a focus on ensuring that such misuse does not lead to tragic consequences.

The company’s pipeline includes a range of products that leverage cutting-edge scientific research to create effective therapeutic solutions. Zena Therapeutics is focused on developing medications that can significantly impact the treatment landscape for mental health and addiction, thereby improving the quality of life for patients. Their approach combines rigorous scientific inquiry with a compassionate understanding of the challenges faced by individuals struggling with these issues, positioning them as a forward-thinking entity in the pharmaceutical industry.

United States

Zena Therapeutics is a drug discovery company, spun-out of Rutgers University, designing new medications for mental health and addiction by improving safety profiles. Currently the work at Zena focuses on acute anxiolytic compounds that do not increase the risk of overdose if taken concomitantly with other central nervous system depressing substances such as opioids and alcohol.

Zena Therapeutics

Company Details